참고문헌
- Altinkaynak K, Bilici M, Bakan N, Akcay F (2012). Circulating levels of IGF-I and IGFBP-3 in gastric cancer. Turk J Med Sci, 42, 1458-62.
- Arkani M, Safaei A, Karimi Kh, Mohsen Vahedi, et al (2012). Association of IGF-1 gene (rs5742612) polymorphism with colorectal cancer. J Sabzevar Univers Med Sc, 19, 109-15.
- Altinkaynak K, Bilici M, Bakan N, Akay F (2012). Circulating levels of IGF-I and IGFBP-3 in gastric cancer. Turk J Med Sci, 42, 1458-62.
- Chan JM, Stampfer MJ, Ma J, et al (2002). Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst, 94, 1099-106. https://doi.org/10.1093/jnci/94.14.1099
- Cheng I, Stram DO, Penney KL, et al (2006). Common genetic variation in IGF1 and prostate cancer risk in the multiethnic cohort. J Natl Cancer Inst, 98 ,123-34. https://doi.org/10.1093/jnci/djj013
- Chen W, Wang S, Tian T, et al (2009). Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies. European J Human Genet, 17, 1668-75. https://doi.org/10.1038/ejhg.2009.86
- Delafontaine P, Song Y, Li Y (2004). Expression, Regulation, and Function of IGF-1, IGF-1R, and IGF-1 Binding Proteins in Blood Vessels. Arterioscler Thromb Vasc Biol, 24, 435-44. https://doi.org/10.1161/01.ATV.0000105902.89459.09
- D'Aloisio AA, JC Schroeder, Kari E, et al (2009). IGF-I and IGFBP-3 polymorphisms in relation to circulating levels among African American and Caucasian women. Cancer Epidemiol Biomarkers Prev, 18, 954-66. https://doi.org/10.1158/1055-9965.EPI-08-0856
- Feik E, Baierl A, Hieger B, et al (2010). Association of IGF1 and IGFBP3 polymorphisms with colorectal polyps and colorectal cancer risk. Cancer Causes Control, 21, 91-7. https://doi.org/10.1007/s10552-009-9438-4
- Forman D, Burley V (2006). Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol, 20, 633-49. https://doi.org/10.1016/j.bpg.2006.04.008
- Furstenberger G, Senn HJ (2002). Insulin-like growth factors and cancer. Lancet Oncol, 3, 298-302. https://doi.org/10.1016/S1470-2045(02)00731-3
- Gao L, Nieters A, Brenner H (2009). Cell proliferation-related genetic polymorphisms and gastric cancer risk: systematic review and meta-analysis. European J Human Genet, 17, 1658-67. https://doi.org/10.1038/ejhg.2009.102
- Harrela M, Koistinen H, Kaprio J, et al (1996) Genetic and environmental components of interindividual variation in circulating levels of IGF-1, IGF-II, IGFBP-3. J Clin Invest, 98, 2612-15. https://doi.org/10.1172/JCI119081
- Karamouzis MV, Papavassiliou AG (2006). The IGF-1 network in lung carcinoma therapeutics. Trends Mol Med, 12, 595-602. https://doi.org/10.1016/j.molmed.2006.10.003
- Katoh T, Nagata N, Kuroda Y, et al (1996). Glutathione S-transferase M1(GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis, 17, 1855-9. https://doi.org/10.1093/carcin/17.9.1855
- Lukanova A, Lundin E, Toniolo P, et al (2002). Circulating levels of insulin-like growth factor-I and risk of ovarian cancer. Int J Cancer, 101, 549-54. https://doi.org/10.1002/ijc.10613
- Lukanova A, Lundin E, Micheli A, et al (2003). Risk of ovarian cancer in relation to prediagnostic levels of C-peptide, insulinlike growth factor binding proteins-1 and -2 (USA, Sweden, Italy). Cancer Causes Control, 14, 285-92. https://doi.org/10.1023/A:1023688603547
- Lacey JV, Potischman N, Madigan MP, et al (2004). Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a US case-control study. Cancer Epidemiol Biomarkers Prev, 13, 607-12.
- Lian H, Zhou Y, Jian Z, Liu R (2014). MiR-323-5p acts as a tumor suppressor by targeting the insulin-like growth factor 1 receptor in human glioma cells. Asian Pac J Cancer Prev, 15, 10181-85.
- McLean MH, El-Omar EM (2014). Genetics of gastric cancer. Nature Rev Gastroenterol Hepatol, 11, 664-74. https://doi.org/10.1038/nrgastro.2014.143
- Malekzadeh R, Derakhshan MH, Malekzadeh Z (2009). Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med, 12, 576-83.
- Miller S, Dykes D, Polesky H (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res, 16, 1215. https://doi.org/10.1093/nar/16.3.1215
- Ma J, Pollak MN, Giovannucci E, et al (1999). Prospective study of colorectal cancer risk in men and plasma levels of insulinlike growth factor (IGF)-I and IGFbinding protein-3. J Natl Cancer Inst, 91, 620-5. https://doi.org/10.1093/jnci/91.7.620
- Nakao M, Hosono S , Ito H , et al (2011). Interaction between IGF-1 polymorphisms and overweight for the risk of pancreatic cancer in Japanese. Int J Mol Epidemiol Genet, 2, 354-66.
- Pollak M (2008). Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer, 8, 915-28. https://doi.org/10.1038/nrc2536
- Qian J, Zhou H, Chen J, et al (2014). Genetic polymorphisms in IGF-I and IGFBP-3 are associated with prostate cancer in the Chinese population. Plos one, 9, 85609-15. https://doi.org/10.1371/journal.pone.0085609
- Rostami M, Kadivar M, Aznab M, Abachi M (2011). Influence of age and gender on association between-765G> C COX-2 genetic polymorphism and gastric adenocarcinoma risk: a case-control study in Iran. Gastroenterol Hepatol Bed Bench, 5, 29-3.
- Smith MG, Hold GL, Tahara E, El-Omar EM (2006). Cellular and molecular aspects of gastric cancer. World J Gastroenterol, 12, 2979-90. https://doi.org/10.3748/wjg.v12.i19.2979
- Setiawan VW, Zhang ZF, Yu GP, et al (2000). GSTT1 and GSTM1 null genotypes and the risk of gastric cancer: a case-control study in a Chinese population. Cancer Epidemiol Biomarkers Prev, 9, 73-80.
- Stadtlander CTH (1999). Molecular epidemiology, pathogenesis and prevention of gastric cancer. Carcinogenesis, 20, 2195-208. https://doi.org/10.1093/carcin/20.12.2195
- Samani AA, Yakar S, LeRoith D, et al (2007). The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev, 28, 20-47. https://doi.org/10.1210/er.2006-0001
- Shitara K, Ito S, Misawa K, et al (2011). Genetic polymorphism of IGF-I predicts recurrence in patients with gastric cancer who have undergone curative gastrectomy. Ann Oncol, 23, 659-64.
- Setiawan VW, Cheng I, Stram DO, et al (2006). Igf-I genetic variation and breast cancer: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev, 15, 172-4. https://doi.org/10.1158/1055-9965.EPI-05-0625
- Tong D, Wen X, Jin Y, et al (2010). Changes of androgen receptor and insulin-like growth factor-1 in LNCaP prostate cancer cells treated with sex hormones and flutamide. Asian Pac J Cancer Prev, 11, 1805-9.
- Tsugane S, Inoue M (2010). Insulin resistance and cancer: epidemiological evidence. Cancer Sci, 101, 1073-79. https://doi.org/10.1111/j.1349-7006.2010.01521.x
- Tao Y, Pinzi V, Bourhis J, Deutsch E (2007). Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway-therapeutic perspectives in cancer. Nat Clin Pract Oncol, 4, 591-602.
- Wong HL, Delellis K, Probst-Hensch N, et al (2005). A new single nucleotide polymorphism in the insulin-like growth factor I regulatory region associates with colorectal cancer risk in Singapore chinese. Cancer Epidemiol Biomarkers Prev, 14, 144-51.
- Wolk A, Mantzoros CS, Andersson SO, et al (1998). Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst, 90, 911-5. https://doi.org/10.1093/jnci/90.12.911
- Yu H, Rohan T (2000). Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst J, 92, 1472-89. https://doi.org/10.1093/jnci/92.18.1472
- Yang H, Qu R, Lin X , et al (2014). IGF-1 from adipose-derived mesenchymal stem cells promoes radioresistance of breast cancer cells. Asian Pac J Cancer Prev, 15, 10115-9.
피인용 문헌
- Body mass index, serum total cholesterol, and risk of gastric high-grade dysplasia vol.95, pp.35, 2016, https://doi.org/10.1097/MD.0000000000004730
- variants with lymph node status and esophagogastric junction adenocarcinoma risk pp.07302312, 2018, https://doi.org/10.1002/jcb.27834